Condition: Primary Open Angle Glaucoma · Sponsor: Sight Sciences, Inc.
To gain early evidence of safety and assess the effectiveness of the intraocular pressure (IOP)-lowering effectiveness of the OMNI 3.0 Surgical System in primary open-angel glaucoma (POAG).
This description comes directly from the study's public registry record.
Jaime Dickerson, PhD · +1 (817) 845-0859 · jdickerson@sightsciences.com
Always discuss trial participation with your own doctor first.
| Panama Eye Center | Panama City, Panama | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06991270